Clinical Trial on Deprescribing Associated With a Psychoeducational Program Using Virtual Reality for Patients With Chronic Pain and Central Sensitization
CompletedNot applicableNCT06964360
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This clinical trial evaluates the effectiveness of the REDOCVR program, an interdisciplinary, psychoeducational intervention designed to support deprescribing of chronic pain medications in primary care. REDOCVR integrates group-based education, physical activation, and emotional regulation techniques, enhanced by immersive virtual reality (VR) content that reinforces therapeutic learning and engagement. Rather than functioning as a standalone tool, VR serves as a complementary catalyst within a person-centered, clinician-guided framework. This randomized trial adds a structured medication tapering component and runs in parallel with a complementary pilot study (ClinicalTrials.gov Identifier: NCT06361706), which evaluates the base REDOCVR program without supervised deprescribing. Both protocols are active and jointly contribute to an adaptive, scalable model of chronic pain care in primary care settings. Outcomes include medication use, emotional well-being, anxiety and depression, quality of life, and usability of VR.
Study details
- Official title
- Clinical Trial on Deprescribing Associated With a Psychoeducational Program Using Virtual Reality for Patients With Chronic Pain and Central Sensitization
- Conditions
- Chronic Pain
- Central Sensitisation
- Opioid-Related Disorders
- Patient Empowerment
- Interventions
- Behavioral: REDOCVR Psychoeducational Program
- Behavioral: Standard Educational Materials
- Sponsor
- Badalona Serveis Assistencials
- Start date
- 2024-05-06
- Primary completion
- 2026-05-22
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults (≥18 years) diagnosed with chronic non-cancer pain persisting for at least 3 months * Assigned to one of the participating primary care centers * Presence of central sensitization symptoms, emotional distress, kinesophobia, or inadequate response to prior treatments * Capacity to provide informed consent and complete questionnaires Exclusion Criteria: * Acute pain conditions (duration \<3 months) * Severe psychiatric or cognitive impairment * Uncontrolled vertigo, epilepsy, or major visual/auditory impairments * Conditions contraindicating use of VR equipment * Inability to attend scheduled sessions
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06964360